CClinicalTrials.gg
RecruitingNCT06195826Updated Jan 8, 2024

Gravity Versus Pump Infusion of Distending Media for Hysteroscopic Myomectomy

An observational study in Hysteroscopic Myomectomy, sponsored by Far Eastern Memorial Hospital. Recruiting at 1 site in Taiwan. Open to female participants aged 20 Years and older. Per ClinicalTrials.gov, last updated 2024-01-08.

Sponsored by Far Eastern Memorial Hospital · Observational

From the registry’s dates

  • Primary completion was expected by Dec 2024, 1 year 9 months ago, but the record still lists the study as recruiting.
  • Started Nov 2023; still recruiting 2 years 10 months later.
Study type
Observational
Model
Case-control
Time perspective
Retrospective
Enrollment
100
Ages
20 Years and older
Sex
Female
01

Study summary

To compare the perioperative outcome between the gravity versus pump infusion groups in women who received hysteroscopic myomectomy

02

Conditions studied

  • Hysteroscopic Myomectomy
03

In context

Lead sponsor

Far Eastern Memorial Hospital is the lead sponsor of 253 studies on the registry; 38 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
20 Years and older
Sexes eligible
Female
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Patients who received hysteroscopic myomectomy

Eligibility criteria

Inclusion Criteria:

  • >20 years old women
  • women who received hysteroscopic myomectomy
05

Study design

Observational model
Case-control
Time perspective
Retrospective
Enrollment
100 participants (estimated)
Patient registry
No

Groups and cohorts

  • gravity infusion

    women who received hysteroscopic myomectomy with gravity infusion method

    Procedure: Gravity infusion

  • pump infusion

    women who received hysteroscopic myomectomy with pump infusion method

    Procedure: Pump infusion

Interventions

  • ProcedureGravity infusion

    hysteroscopic myomectomy with the gravity infusion method

  • ProcedurePump infusion

    hysteroscopic myomectomy with the pump infusion method

06

What researchers measure

Primary outcomes

  1. Infusion volume of distension medium

    Infusion volume (mL) of distension medium in the uterine cavity between the gravity and pump infusion methods for hysterosopic myomectomy

    Time frame: 1 week

Secondary outcomes

  1. Intraoperative blood loss

    Intraoperative blood loss (mL) between the gravity and pump infusion methods for hysterosopic myomectomy

    Time frame: 1 week

  2. Postoperative pain

    Postoperative pain (visual analogue scale 0-10) in the recovery room between the gravity versus pump infusion methods for hysterosopic myomectomy.

    Time frame: 1 week

  3. Surgical time

    Surgical time (minutes) between the gravity versus pump infusion methods for hysterosopic myomectomy

    Time frame: 1 week

07

Study locations

1 of 1 sites recruiting
  • Department of Obstetrics and Gynecology, Far Eastern Memorial Hospital
    Banqiao, New Taipei 22050, Taiwan
    Recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 8, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06195826
Lead sponsor
Far Eastern Memorial Hospital
Responsible party
Sheng-Mou Hsiao (Chief, Department of Obstetrics & Gynecology, Far Eastern Memorial Hospital) — Principal investigator
First posted
Jan 8, 2024
Start date
Nov 21, 2023
Primary completion
Dec 31, 2024 (estimated)
Completion
Dec 31, 2024 (estimated)
Last update
Jan 8, 2024

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion